Cencora, Inc. (COR) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
1 WEST FIRST AVENUE CONSHOHOCKEN, PA 19428 |
| State of Incorp. | DE |
| Fiscal Year End | September 30 |
| Industry (SIC) | 5122 - Drugs, Drug Proprietaries, and Druggists' Sundries (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in millions)
| 9/30/2025 | 12/31/2024 MRQ | 9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | 9/30/2020 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 3,224 | 3,133 | 2,592 | 3,388 | 2,547 | 4,598 | |||
| Cash and cash equivalent | 3,224 | 3,133 | 2,592 | 3,388 | 2,547 | 4,598 | |||
| Receivables | 24,546 | 23,960 | 20,988 | 18,625 | 18,389 | 14,335 | |||
| Inventory, net of allowances, customer advances and progress billings | 20,508 | 18,999 | 17,455 | 15,556 | 15,368 | 12,589 | |||
| Inventory | 20,508 | 18,999 | 17,455 | 15,556 | 15,368 | 12,589 | |||
| Disposal group, including discontinued operation | 373 | ||||||||
| Other undisclosed current assets | 1,709 | 1,626 | 1,764 | 2,020 | 2,125 | 1,534 | |||
| Total current assets: | 49,987 | 47,718 | 42,799 | 39,590 | 38,803 | 33,056 | |||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 2,100 | 2,181 | 2,135 | 2,135 | 2,163 | 1,485 | |||
| Intangible assets, net (including goodwill) | 12,859 | 13,319 | 14,006 | 12,837 | 14,287 | 8,593 | |||
| Goodwill | 9,177 | 9,318 | 9,574 | 8,504 | 9,031 | 6,707 | |||
| Intangible assets, net (excluding goodwill) | 3,682 | 4,001 | 4,432 | 4,333 | 5,257 | 1,886 | |||
| Deferred income tax assets | 219 | 246 | 201 | 238 | 291 | 362 | |||
| Other noncurrent assets | 3,889 | 3,637 | 3,418 | 1,762 | 1,794 | 780 | |||
| Total noncurrent assets: | 19,068 | 19,384 | 19,760 | 16,971 | 18,535 | 11,219 | |||
| TOTAL ASSETS: | 69,054 | 67,102 | 62,559 | 56,561 | 57,338 | 44,275 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 52,296 | 53,701 | 48,190 | 42,407 | 40,866 | 33,352 | |||
| Accounts payable | 49,911 | 50,942 | 45,836 | 40,193 | 38,010 | 31,705 | |||
| Accrued liabilities | 2,385 | 2,759 | 2,354 | 2,215 | 2,856 | 1,647 | |||
| Debt | 2,213 | 576 | 641 | 1,070 | 300 | 501 | |||
| Disposal group, including discontinued operation | 192 | ||||||||
| Total current liabilities: | 54,509 | 54,277 | 48,831 | 43,478 | 41,359 | 33,853 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 5,935 | 3,812 | 4,146 | 4,632 | 6,384 | 3,618 | |||
| Long-term debt, excluding current maturities | 5,935 | 3,812 | 4,146 | 4,632 | 6,384 | 3,618 | |||
| Liabilities, other than long-term debt | 8,248 | 8,226 | 8,915 | 8,379 | 9,011 | 7,643 | |||
| Accounts payable and accrued liabilities | 303 | 292 | 311 | 320 | 281 | 285 | |||
| Deferred income tax liabilities | 1,586 | 1,644 | 1,658 | 1,620 | 1,685 | 686 | |||
| Estimated litigation liability | 4,297 | 4,297 | 5,062 | 5,462 | 5,962 | 6,199 | |||
| Other liabilities | 2,062 | 1,994 | 1,885 | 977 | 1,083 | 473 | |||
| Total noncurrent liabilities: | 14,183 | 12,038 | 13,061 | 13,011 | 15,395 | 11,261 | |||
| Total liabilities: | 68,692 | 66,315 | 61,892 | 56,489 | 56,753 | 45,114 | |||
| Equity | |||||||||
| Equity, attributable to parent | 227 | 646 | 522 | (212) | 223 | (1,019) | |||
| Common stock | 3 | 3 | 3 | 3 | 3 | 3 | |||
| Treasury stock, value | (10,278) | (9,816) | (8,247) | (7,020) | (6,470) | (6,513) | |||
| Additional paid in capital | 6,106 | 6,031 | 5,845 | 5,659 | 5,465 | 5,082 | |||
| Accumulated other comprehensive loss | (1,400) | (989) | (1,403) | (1,831) | (445) | (109) | |||
| Retained earnings | 5,795 | 5,417 | 4,324 | 2,978 | 1,671 | 518 | |||
| Equity, attributable to noncontrolling interest | 135 | 141 | 144 | 283 | 361 | 179 | |||
| Total equity: | 362 | 787 | 666 | 71 | 584 | (840) | |||
| TOTAL LIABILITIES AND EQUITY: | 69,054 | 67,102 | 62,559 | 56,561 | 57,338 | 44,275 | |||
Income Statement (P&L) ($ in millions)
| 9/30/2025 | 12/31/2024 TTM | 9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | 9/30/2020 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 303,193 | 293,959 | 262,173 | 238,587 | 213,989 | 189,894 | ||
| Cost of revenue (Cost of Product and Service Sold) | (293,194) | (284,049) | (253,214) | (230,291) | (207,046) | (184,702) | ||
| Gross profit: | 9,999 | 9,910 | 8,959 | 8,296 | 6,943 | 5,192 | ||
| Operating expenses | (7,279) | (7,090) | (6,643) | (5,698) | (4,571) | (10,327) | ||
| Other operating expense, net (Other Expenses) | ||||||||
| Other undisclosed operating income (loss) | (662) | (645) | 25 | (232) | (18) | |||
| Operating income (loss): | 2,059 | 2,175 | 2,341 | 2,366 | 2,354 | (5,135) | ||
| Nonoperating income (expense) | (73) | (14) | 49 | 27 | 42 | 2 | ||
| Investment income, nonoperating | ||||||||
| Loss, foreign currency transaction, before tax | (14) | (3) | ||||||
| Interest and debt expense | (7) | (9) | (12) | (10) | (22) | |||
| Other undisclosed loss from continuing operations before equity method investments, income taxes | (7) | (138) | ||||||
| Income (loss) from continuing operations before equity method investments, income taxes: | 1,978 | 2,154 | 2,381 | 2,382 | 2,386 | (5,294) | ||
| Other undisclosed loss from continuing operations before income taxes | (137) | (150) | (220) | (199) | (164) | |||
| Income (loss) from continuing operations before income taxes: | 1,841 | 2,004 | 2,161 | 2,183 | 2,222 | (5,294) | ||
| Income tax expense (benefit) | (431) | (485) | (428) | (517) | (677) | 1,894 | ||
| Income (loss) from continuing operations: | 1,410 | 1,519 | 1,733 | 1,667 | 1,545 | (3,400) | ||
| Income (loss) before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | 1,667 | 1,545 | (3,400) | |
| Net income (loss): | 1,410 | 1,519 | 1,733 | 1,667 | 1,545 | (3,400) | ||
| Net income (loss) attributable to noncontrolling interest | (14) | (10) | 13 | 32 | (5) | (9) | ||
| Net income (loss) available to common stockholders, diluted: | 1,396 | 1,509 | 1,745 | 1,699 | 1,540 | (3,409) | ||
Comprehensive Income ($ in millions)
| 9/30/2025 | 12/31/2024 TTM | 9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | 9/30/2020 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | 1,410 | 1,519 | 1,733 | 1,667 | 1,545 | (3,400) | ||
| Other comprehensive income (loss) | (288) | 405 | 387 | (1,422) | (335) | (9) | ||
| Comprehensive income (loss): | 1,122 | 1,924 | 2,119 | 245 | 1,210 | (3,409) | ||
| Comprehensive income (loss), net of tax, attributable to noncontrolling interest | 11 | (1) | 54 | 69 | (7) | 3 | ||
| Comprehensive income (loss), net of tax, attributable to parent: | 1,133 | 1,923 | 2,174 | 313 | 1,203 | (3,406) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.